We are iethico
We bridge the gap between medicine supply and demand with a unique, one-of-a-kind solution that harnesses the power of networks and data
Our medicine sourcing solution is award winning
Finalist for The Spectator Economic Innovator of the Year 2023.
Announcement in November 2023
C+D Judges shortlisted iethico for
Online Innovation of the Year award
KPMG Finalist for the UK Tech Innovator awards 2023.
Winner of Leadership in Diversity 2023
National Medilink UK Healthcare Business Awards 2023.
FInalist for Start up
Winner of the Best Start up award, and in Judge's opinion, likely to achieve impressive feats in the future
In recognition of iethico developing a digital healthcare solution that improves patient care and reduces costs
In recognition of early-stage scaleups who are making waves with their innovative solution
iethico Award from Innovate UK Funding to develop its Medicine Shortage Reporting Tool
iethico's business and tech team have strong sector experience
iethico exhibiting its medicine shortage solution at UHCW NHS Trust Innovation Hub
Debra Ainge joins the panel as a keynote speaker to discuss advancements women are making in the industry
In an interview with The European Pharmaceutical Manufacturer, Peter Shone talks AI platform to predict global drug shortages before they happen
Prestigious Health Data Science Event. Led by LLSA and Medilink. Debra Ainge joins panel of experts from University of Leicester for leveraging digital solutions within health data science
Claudio Zurzica invited to join the panel for a round table discussion on medicine shortages in Ireland led by Azure Pharma
iethico at Venturefest 2023 in the tech demo zone
Offices at the University of Warwick Science Park’s Business Innovation Centre in Binley through the Ignite incubator programme
Our CTO, Peter Shone joins a round table discussion on the healthtech revolution implications for health outcomes
Debra Ainge talks AI, the journey of founding iethico's drug shortages solution and starting a business with the UK Startup Magazine
£625,000 investment MEIF managed by Midven, part of the Future Planet Capital Group to help combat global medicine shortages
2022 Digital Health Accelerator Program with the East Midlands Academic Health Science Network - Igniting Innovation for the NHS
Debra Ainge
Debra Ainge
Debra Ainge
Chief Executive Officer
Highly experienced having demonstrated success with a record of driving growth both organically and through M&A.
Well-versed in leading organizations from start-up to over 2000 personnel as well managing large strategic projects such as M&A, ERP, international expansion initiatives and more.
Previously created and developed a proprietary digital platform
Peter Shone
Debra Ainge
Debra Ainge
Chief Technology Officer
A distinguished tech guru with decades of experience.
10 years as CTO of a CRO, overseeing the development and implementation of innovative clinical trial systems used internationally by thousands.
Expertise extends to AI engineering for Rolls Royce aviation, while also crafting military intelligence solutions throughout multiple governments worldwide
Renee Kalia
Debra Ainge
Dr Suzanne Pavon
Operations
25 years of customer management experience across multiple industry verticals. Leadership of contact centre teams 500+ driving sales, managing procurement, account management, quality, compliance, and continuous improvement.
Recognised by the Institute of Customer Services for delivering accredited world class customer service to healthcare professionals
Dr Suzanne Pavon
Dr Suzanne Pavon
Dr Suzanne Pavon
Quality and Regulatory
Entrepreneurial, quality-focused, senior exec. 23+ yrs global experience in pharma, biotech, and CRO. Executive leadership in Quality Management, Compliance, and Operations.
Worked at TFS CRO, Piramal, Novartis, uniQure, Teva, Sanofi, The Mayo Clinic. PhD in oncology, PharmD, CPHQ.
Graduate of Philadelphia University and Harvard School of Public Health.
James Haddleton
Dr Suzanne Pavon
James Haddleton
NED, Business Services
25 years of commercial law experience including major roles such as Group Legal Counsel and Co. Secretary for an AIM-listed pharmaceutical corporation - leading projects that diminished risk while simultaneously augmenting efficiency and quality levels across contracting procedures, governance initiatives, and compliance systems.
Today, James is the CEO of Haddletons
Gursh Panesar
Dr Suzanne Pavon
James Haddleton
VP of Sales
Over 25 years experience in Pharmaceutical Wholesale across Primary Care, UK, Europe, and Global Markets..
Track record of delivering over £350m sales across Generics, PI’s, UK Branded, OTC, Medical devices, and Nutraceuticals.
Strong relationship with EU suppliers. Worked at Day Lewis and Uni Health Distribution. Gursh holds a MSc Med Chemistry & Drug Metabolism
Leon Rudd
Tiago Galvão
Tiago Galvão
Marketing
Experienced commercial business leader in highly regulated, complex markets.
Excels at initiating go-to market strategies for B2C/B2B sectors. Strategic Marketing, Business Turnaround, Multi Channel Delivery, through to launching Products and Services with successful longterm results.
Impressive regional growth with benefits in tech, mobile health and pharma
Tiago Galvão
Tiago Galvão
Tiago Galvão
Pharmacist, CEO & Investor
Highly accomplished executive in the pharmaceutical industry. Over two decades of experience.
Currently the CEO Empifarma. Previous CEO Alliance Healthcare S.A. Portugal and Board Member of National Association of Pharmacies (ANF) for 10 years.
Co-founded Rede Claro and United Healthcare, distribuicao farmaceutica. Holds an Executive MBA from AESE Business School
We work and partner with the best
